This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Upgrades For Wednesday
This Super Micro Computer Analyst Turns Bearish; Here Are Top 5 Upgrades For Wednesday
這位超微電腦分析師變得看淡；這是週三的五個頂級升級方案
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- Keybanc analyst Steve Barger downgraded the rating for Myers Industries, Inc. (NYSE:MYE) from Overweight to Sector Weight. Myers shares closed at $11.39 on Tuesday. See how other analysts view this stock.
- TD Cowen analyst Vivien Azer downgraded the rating for Brown-Forman Corporation (NYSE:BF) from Buy to Hold and lowered the price target from $50 to $48. Brown-Forman shares closed at $43.74 on Tuesday. See how other analysts view this stock.
- JP Morgan analyst Samik Chatterjee downgraded Super Micro Computer, Inc. (NASDAQ:SMCI) from Neutral to Underweight and slashed the price target from $50 to $23. Super Micro Computer shares closed at $27.70 on Tuesday. See how other analysts view this stock.
- B of A Securities analyst Kevin Fischbeck downgraded Ardent Health Partners, Inc. (NYSE:ARDT) from Buy to Neutral and lowered the price target from $22 to $19. Ardent Health Partners shares closed at $18.05 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Oren Livnat downgraded the rating for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) from Buy to Neutral. Verrica Pharmaceuticals shares closed at $0.7975 on Tuesday. See how other analysts view this stock.
- Keybanc分析師Steve Barger將Myers Industries, Inc. (紐交所:MYE) 的評級由超買入調降至板塊權重。Myers股價週二收於$11.39。查看其他分析師對這隻股票的看法。
- TD Cowen分析師Vivien Azer將Brown-Forman Corporation (紐交所:BF) 的評級由買入調降至持有，並將價格目標從$50降至$48。Brown-Forman股價週二收於$43.74。查看其他分析師對這隻股票的看法。
- JP Morgan分析師Samik Chatterjee將超微電腦, Inc. (納斯達克:SMCI) 的評級由中立調降至低於市場表現，並將價格目標從$50調降至$23。超微電腦股價週二收於$27.70。查看其他分析師對這隻股票的看法。
- b of A Securities分析師Kevin Fischbeck將Ardent Health Partners, Inc. (紐交所:ARDT) 的評級由買入調降至中立，並將價格目標從$22降至$19。Ardent Health Partners股價週二收於$18.05。查看其他分析師對這隻股票的看法。
- HC Wainwright & Co.分析師Oren Livnat將verrica製藥公司, Inc. (納斯達克:VRCA) 的評級由買入調降至中立。verrica製藥公司股價週二收於$0.7975。查看其他分析師對這隻股票的看法。
Considering buying CHWY stock? Here's what analysts think:
考慮買入CHWY股票？以下是分析師的看法：
Read More:
閱讀更多：
- Cramer Says He Can't Recommend This Major Automaker, Ceva Is 'Way Too High'
- 克雷默表示，他無法推薦這家主要的汽車製造商，Ceva股價太高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。